Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

6825 ARTÍCULOS , VIENDO DEL 4621 AL 4635

Testing visual perception in dementia with Lewy bodies and Alzheimer disease

Wood JS, Firbank MJ, Mosimann UP, Watson R, Barber R, Blamire AM, O'Brien JT.

Am J Geriatr Psychiatry. 2013 Jun;21(6):501-8. doi: 10.1016/j.jagp.2012.11.015. Epub 2013 Jan 11.

Angiotensin converting enzyme inhibitors and Alzheimer disease in the presence of the apolipoprotein E4 allele

Qiu WW, Lai A, Mon T, Mwamburi M, Taylor W, Rosenzweig J, Kowall N, Stern R, Zhu H, Steffens DC.

Am J Geriatr Psychiatry. 2014 Feb;22(2):177-85. doi: 10.1016/j.jagp.2012.08.017. Epub 2013 Apr 3.

[Aβ immunotherapy for Alzheimer's disease]

Sakai K, Yamada M.

Brain Nerve. 2013 Apr;65(4):461-8.

Vascular contribution to Alzheimer disease: predictors of rapid progression

Diomedi M, Misaggi G.

CNS Neurol Disord Drug Targets. 2013 Jun;12(4):532-7. doi: 10.2174/1871527311312040015.

Vascular endothelial growth factor gene promoter polymorphisms and Alzheimer's disease risk: a meta-analysis

Liu SY, Zeng FF, Chen ZW, Wang CY, Zhao B, Li KS.

CNS Neurosci Ther. 2013 Jul;19(7):469-76. doi: 10.1111/cns.12093. Epub 2013 Apr 10.

Diagnosis and management of Alzheimer's disease: past, present and future ethical issues

Gauthier S, Leuzy A, Racine E, Rosa-Neto P.

Prog Neurobiol. 2013 Nov;110:102-13. doi: 10.1016/j.pneurobio.2013.01.003. Epub 2013 Apr 8.

[Rivastigmine as treatment for patients with mild to moderately severe Alzheimer disease under normal clinical practice conditions. The ENTERPRISE study]

Cruz Jentoft AJ, Hernández B.

Neurologia. 2014 Jan-Feb;29(1):1-10. doi: 10.1016/j.nrl.2013.01.008. Epub 2013 Apr 10.

Fluorine-18 radiolabeled heterocycles as PET tracers for imaging β-amyloid plaques in Alzheimer's disease

Zeng F, Goodman MM.

Curr Top Med Chem. 2013;13(8):909-19. doi: 10.2174/1568026611313080004.

Does cognitive profile distinguish Lewy body disease from Alzheimer's disease in the early stages?

Blanc F.

J Neurol Neurosurg Psychiatry. 2013 Dec;84(12):1299-300. doi: 10.1136/jnnp-2012-304694. Epub 2013 Apr 16.

Twenty-year changes in dementia occurrence suggest decreasing incidence in central Stockholm, Sweden

Qiu C, von Strauss E, Bäckman L, Winblad B, Fratiglioni L.

Neurology. 2013 May 14;80(20):1888-94. doi: 10.1212/WNL.0b013e318292a2f9. Epub 2013 Apr 17.

Human culture and the future dementia epidemic: crisis or crossroads?

Whalley LJ, Smyth KA.

Neurology. 2013 May 14;80(20):1824-5. doi: 10.1212/WNL.0b013e318292a368. Epub 2013 Apr 17.

The GERAS Study: a prospective observational study of costs and resource use in community dwellers with Alzheimer's disease in three European countries--study design and baseline findings

Wimo A, Reed CC, Dodel R, Belger M, Jones RW, Happich M, Argimon JM, Bruno G, Novick D, Vellas B, Haro JM.

J Alzheimers Dis. 2013;36(2):385-99. doi: 10.3233/JAD-122392.

Decisive role of Reelin signaling during early stages of Alzheimer's disease

Krstic D, Pfister S, Notter T, Knuesel I.

Neuroscience. 2013 Aug 29;246:108-16. doi: 10.1016/j.neuroscience.2013.04.042. Epub 2013 Apr 28.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias